Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 6
Submit an article Journal homepage
49
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Relapsed Hodgkin's Lymphoma: Immunostaining Patterns in Relation to Survival

Rose-Marie Amini Department of Genetics and Pathology, University of Uppsala, Akademiska sjukhuset, S-751 85, Uppsala, Sweden
,
Gunilla Enblad Department of Oncology, Radiology and Clinical Immunology, University of Uppsala, Akademiska sjukhuset, S-751 85, Uppsala, Sweden
,
Peter Engström Department of Genetics and Pathology, University of Uppsala, Akademiska sjukhuset, S-751 85, Uppsala, Sweden
,
Birger Christensson Department of Pathology, Huddinge sjukhus, Stockholm, Sweden
,
Bengt Glimelius Department of Oncology, Radiology and Clinical Immunology, University of Uppsala, Akademiska sjukhuset, S-751 85, Uppsala, Sweden
&
Christer Sundström Department of Genetics and Pathology, University of Uppsala, Akademiska sjukhuset, S-751 85, Uppsala, Sweden
Pages 1253-1260 | Published online: 01 Jul 2009

  • Boafante, V., Sanloro, A., Viviani, S., Devizzi, L., Balzarotti, M., Soneini, K, Zanini, M., Valagussa, P. and Bonnadonna, G. (1997) "Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD". Journal of Clinical Oncology 15, 528-534.
  • Longo, D.L., Duffey, P.L., Young, R.C., Hubbard, S.M., Ihde, D.C., Glalstein, E., Phares, J.C., JaIIe, E.S., Urba, W.J. and DeVila, V.T. (1992) "Conventional-dose salvage combination chemotherapy to patients relapsing with Hodgkin's disease after combination chemotherapy: The low probability for cure". Journal of Clinical Oncology 10, 210-218.
  • Brandt, L. Kimby, E., Nygren, P. and Gtimelius, B. (2001) "A systematic overview of chemotherapy effects in Hodgkin's disease". Acta Oncologica 41, 185-197.
  • Buchkovich, K., Duify, L.A. and Harlow, E. (1989) "The retinoblastoma protein is phosphorylated during specific phases of the cell cycle". Cell 58, 1097 1105.
  • Morente, M.M., Piris, M.A., Abraira, V., Acevedo, A., Aguilera, B., Bellas, C., Fraga, M., Garcia-Del-Moral, R., Gomez-Marcos, R. Menarguez, J., Oliva, H., Sanchez-Beato, M. and Montalban, C. (1997) "Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index and absence of Epstein-Barr virus latent membrane protein 1 expression". Blood 90, 2429-2436.
  • Navaratnam, S., Williams, G.J., Rubinger, M., Pettigrew, N.M., Mowat, M.R., Begleiter, A. and Johnston, J.B. (1998) "Expression of p53 predicts treatment failure in aggressive non-hodgkin lymphomas". Leukemia and Lymphoma 29 (1 -2), 139-144.
  • Villuendas, R., Piris, M.A., Algara, P., Sanchez-Beato, M., SunctiesVerde, L., Martinez, J.C., Otiadre, J.L., Garcia, P., Lopez, C. and Martinez, P. (1993) "The expression of p53 protein in nonHodgkin's lymphomas is not always dependent on p53 gene mutations". Blood 82, 3151-3156.
  • Iclukawa, A., Kinoshita, T., Walanabe, T., Kato, H., Nagai, H., Tsushita. K., Saito, H. and Hotta, T. (1997) "Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma". New England Journal of Medicine 337, 529 -534.
  • Brink, A.A., Oudejans, J.J., van den Brule, A.J., Kluin, P.M., Horstman, A., Ossenkoppele, G.J., Van Heerde, P., Jiwa, M, and Meijer, C.J. (1998) "Low p53 and high bcl-2 expression in ReedStemberg cells predict poor clinical outcome for Hodgkin's disease: involvement of apoptosis resistance'?". Modern Pathology 11, 376- 383.
  • Smolewski, P., Niewiadotmka, H., Blonski, J.Z., Robak, T. and Krykowski, E. (1998) "Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on ReedSternberg cells: prognostic significance in Hodgkin's disease". Netiplasma 45, 140-147.
  • Boiocchi, M., Dolcetti, R., Re, VD., Gloghini, A. and Carbone, A. (1993) "Demonstration of unique Epstein-Barr virus-positive cellular clone in metachronous multiple localizations of Hodgkin's disease". American Journal of Pathology 142, 33-38.
  • Ladanyi, M., Cavalchire, G., Morris, S.W., Downing, J. and Filippa, D.A. (1994) "Reverse transcriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-associaled t(2,5) translocation in Hodgkin's disease". American Journal of Pathology 145, 1296-1300.
  • Orscheschek, K., Merz, H., Hell, J., Binder, T, Bartels, H. and Feller, A.C. (1995) "Large-cell anaplastic lymphoma-speciric translocation (t(2;5)(p23;q35)) in Hodgkin's disease: indication of a common pathogenesis?". Lancet 345, 87-90.
  • Herbst, H., Anagnostopoulos, J., Heinze, B., Durkop, H., Hummel, M. and Stein, H. (1995) "ALK gene products in anaplastic large cell lymphomas and Hodgkin's disease". Blood 86, 1694-1700.
  • Sortis, A H., Luthra, R., Papadimitracopoulou, V., Waasdorp, M., Dimopoulos, MA., McBride. J.A., Cabanillas, E. Duvic, M., Deisseroth, A., Morris, S.W. and Pugh, W.C. (1996) "Amplification of genomic DNA demonstrates the presence of the t(2:5)(p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin Iymphomas, Hodgkin's disease or lymphomatoid papulosis". Blood 88, 1771-1779.
  • Yee, H.T., Ponzoni, M., Merson, A., Goldstern, M., Scarpa, A., Chilosi, M., Menestrina, F. Pittaluga, S., De Wolf-Peelers, C., Shkita, M., Mori, S. Frizzera, G and Inghirami, G (19961 "Molecular characterization of the t(2:5)(p23:q35) translocation in anaplastic large cell lymphoma (Kil) and Hodgkin's disease". Blood 87, 1081-1088.
  • Pulford, K., Lamant, L., Morris, S.W., Butler, L.H., Wood, K.M., Stroud, D., Delsol, G. and Mason, D.Y. (1997) "Detection of anaplastic lymphoma kinase (ALK) and nuclear protein oucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK I". Blood 89, 1394-1404.
  • Glimeliub, B., Enblad, G. Kälkner, M., Gustavsson, A., Jakobsson, M., Branehög, I., Lenner, P. and Björkholm. M. (1996) 'Treatment of Hodgkin's disease. The Swedish national health care programme experience". Leukemia and Lymphoma 21, 71-78.
  • Carbone, P.P., Kaplan, H.S., Musshof, K., Smithers, D.W. and Tubiana, M. (1971) "Report on the committe on Hodgkin's disease staging". Cancer Research 31, 1960- 1961.
  • Jox, A., Zander, T., Kornacker, M., Kanzler, H., Kuppers, R., Diehl, V. and Wolf, J. (1998) "Detection of identical Hodgkin-Reedstemberg cells specific immunoglobulin gene rearrangements in a patient with Hodgkin's disease of mixed cellularity subtype at primary diagnosis and in relapse two and a half years later". Annals of Oncology 9, 283-287.
  • Vockerodt, M., Soares, M., Kanzler, H., Kuppers, R., Kube, D., Hansmann, M-L., Diehl, V. and Tesch, H. (1998) "Detection of clonal Hodgkin and Reed-Sternberg cells with identical somatically mutated and rearranged VH genes in different biopsies in relapsed Hodgkin's disease". Blood 192, 2899 -2907.
  • Poppema, S. and van den Berg, A. (2000) "Interaction between host T cells and Reed-Stemberg cells in Hodgkin lymphomas". Seminars in Cancer Biology 10, 345-350.
  • Amini, R-M., Enblad, G., Sundström, C. and Glimelius, B. (1997) "Patients suffering from both Hudgkin's disease and NonHodgkin's lymphoma: a clinico-pathological and immuno-histochemical population based study of 32 patients". International Journal of Concer 71, 510-516.
  • Hapberp, H., Ahlström, H.K., Magnusson, A., Sundström, C. and Åström, G.K (2000) "Value of transsternal core biopsy in patients with a newly diagnosed mediastinal mass". Acta Oncolagica 39, 195-198.
  • Naresh, K.N., O'Conor, G.T., Soman, C.S., Johnson, J., Advani.S.H., Magrath, L.T, and Bhatia, K.G. (1997) " A study of p53 protein, pruliferating cell nuclear antigen, and p21 in Hodgkin's disease at presentation and relapse". Human Pathology 28, 549-555.
  • Xerri, L., Bouabdallah, R., Camerlo, J. and Hassoun, J. (1994) "Expression of the p53 gene in Hodgkin's disease: dissociation between immunohistochemstry and clinicopathological data". Human Patholngy 25, 449-454.
  • Montesinos-Rongen, M., Roers, A., Kuppers, R., Rajewsky, K. and Hansmann, M.L. (1999) "Mitation of the p53 gene is not a typical feature of Hodgkin and Reed-Sternberg cells in Hodgkin's disease". Blood 94, 1755-1760.
  • Sanchez-Beato, M., Martinez-Montero, J.C., Doussis-Anagnosto poulo, T.A., Gatter, K.C. Garcia, J., Garcia, JF., LLoret, E. and Piris, M.A. (1996) "Anomalous retinoblastoma protein expression in Sternberg- Reed cells in Hodgkin's disease: a comparative study wilh p53 and Ki67 expression". British Journal of Cancer 74, 1056-1062.
  • Enblad, G., Sandvej, K., Sundström, C., Pallesen, G. and Glirnelius, B. (1999) "EBV positivity in Hodgkin's disease in an unselected population". Acta Oncologica 38, 425-430.
  • Kuppers, R. and Rajewsky, K. (1998) "The origin of Hodgkin and Reed-Stemberg cells in Hodgkin's disease". Annual Reviews of Immunology 16, 471-493.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.